It’s estimated that human adults make about 35,000 decisions a day — the percentage of good decisions depends on the adult. These choices can be as banal as deciding to roll or crumple toilet paper or ...

In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...

The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing subjectivity into what should be an objective process.

The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...